Communicating breast cancer risks: a genetic counsellor's role in improving patient understanding to increase informed decision-making

Completed

• Conditions: Mammary carcinoma; Cancer; Malignant neoplasm of the breast

• Registration Number: ISRCTN14566836
• Lead Sponsor: VU University Medical Centre/EMGO-Institute (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09-12
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

A consecutive series of women who are first time attenders applying for genetic breast cancer counselling at three Dutch Clinical Genetic Centres (VUmc Amsterdam, LUMC Leiden and UMCG Groningen) are invited to participate in the study.

Exclusion Criteria

Women are considered ineligible if they are:
1. Less than 18 years of age
2. Have evident psychiatric illness
3. Have a terminal disease
4. Women with a personal history of breast or ovarian cancer

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adequate risk perception

Secondary Outcome Measures

Name	Time	Method
1. Cognitive evaluation (knowledge about hereditary breast cancer, informed decisions)<br>2. Psychological and affective evaluation ([cancer] anxiety, worry)<br>3. Evaluation of perceived benefits and helpfulness of the additional risk counselling<br>4. Expected intention or actual uptake of methods of breast cancer detection and prevention